Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  93 results for ""COVID-19""

Your Filters

Content Provider : MEDLINE Language : english Language : french Publisher : nature publishing group Subject : europe Subject : uk Subject : vaccines Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period.

  • Authors : Ao D; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Sichuan, People's Republic of China.; He X

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Dec 21; Vol. 8 (1), pp. 466. Date of Electronic Publication: 2023 Dec 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Model-informed health and socio-economic benefits of enhancing global equity and access to Covid-19 vaccines.

  • Authors : Italia M; Department of Electronic, Information, and Bioengineering, Politecnico di Milano, Milan, Italy. .; Della Rossa F

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Scientific reports [Sci Rep] 2023 Dec 07; Vol. 13 (1), pp. 21707. Date of Electronic Publication: 2023 Dec 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.

  • Authors : Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857, Singapore.; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117547, Singapore.

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Scientific reports [Sci Rep] 2023 Nov 20; Vol. 13 (1), pp. 20263. Date of Electronic Publication: 2023 Nov 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Investigating the effects of vaccine on COVID-19 disease propagation using a Bayesian approach.

  • Authors : Ling L; Lyles School of Civil Engineering, Purdue University, West Lafayette city, 47906, USA.; Ukkusuri SV

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

  • Source: Scientific reports [Sci Rep] 2023 Aug 17; Vol. 13 (1), pp. 13374. Date of Electronic Publication: 2023 Aug 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: Scientific reports [Sci Rep] 2023 Oct 03; Vol. 13 (1), pp. 16579. Date of Electronic Publication: 2023 Oct 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023.

  • Authors : Puenpa J; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Chansaenroj J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/genetics ; Vaccines*SARS-CoV-2 variants

  • Source: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 645. Date of Electronic Publication: 2024 Jan 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.

  • Authors : Nash D; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA. .; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 644. Date of Electronic Publication: 2024 Jan 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia.

  • Authors : Uusküla A; Department of Family Medicine and Public Health, University of Tartu, 50411, Tartu, Estonia. .; Pisarev H

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Scientific reports [Sci Rep] 2023 Nov 21; Vol. 13 (1), pp. 20347. Date of Electronic Publication: 2023 Nov 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Public support for more stringent vaccine policies increases with vaccine effectiveness.

  • Authors : Koenig R; Department of Political Economy, King's College London, London, WC2R 2LS, UK.; Savani MM

Subjects: COVID-19 Vaccines* ; Vaccines*; Humans

  • Source: Scientific reports [Sci Rep] 2024 Jan 19; Vol. 14 (1), pp. 1748. Date of Electronic Publication: 2024 Jan 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Promote to protect: data-driven computational model of peer influence for vaccine perception.

Subjects: COVID-19 Vaccines* ; Vaccines*; Humans

  • Source: Scientific reports [Sci Rep] 2024 Jan 03; Vol. 14 (1), pp. 306. Date of Electronic Publication: 2024 Jan 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  93 results for ""COVID-19""